Toshiba CT Delivers More Consistent Results with its Adaptive Diagnostics Technology

Published on:

Lowering CT dose and improving workflow are not choices that clinicians should have to make, so Toshiba CT is putting customers first by providing the industry’s best solutions to solve these challenges. To make complex exams easier, lower dose and improve diagnostic accuracy and reproducibility, Toshiba is introducing its Adaptive Diagnostics CT technology.
Available on the AquilionTM ONE, Aquilion ONE ViSION Edition and Aquilion PRIME, Toshiba’s Adaptive Diagnostics includes:

  • SURESubtractionTM has the ability to remove bone and calcium from data sets while allowing clinicians to view tumors or arteries at risk. Currently available for brain, bone, carotid and coronary artery (pending FDA clearance) exams.
  • Metal Artifact Reduction (MAR) (pending FDA clearance) removes streak artifacts in images due to metallic implants in the body.
  • SURECardioTM Prospective with arrhythmia detection is a unique application that dramatically lowers patient dose during coronary CTA exams using a helical acquisition technique to provide one continuous image instead of multiple images. It automatically detects and adjusts to patients with irregular heartbeats, providing quicker, more conclusive exam results.
  • Variable Helical Pitch (vHP) has the ability to automatically change an ECG-gated to a non-ECG-gated acquisition, reducing IV contrast and radiation dose. vHP can

significantly reduce radiation dose over the use of a single-gated pitch setting.

  • Dual Energy (pending FDA clearance) uses two energies during one CT scan, providing clinicians with more data to help quantify and characterize anatomy and lesions. As a result, exam times and radiation dose are both reduced.

“Today’s healthcare environment is changing and there are new clinical challenges that our customers are facing,” says Satrajit Misra, senior director, CT Business Unit, Toshiba. “Adaptive Diagnostics is an example of how Toshiba develops technologies that meet the needs of providers today and in the future, giving them the tools to improve quality of care while reducing costs.”

Toshiba is showcasing its Aquilion product line and Adaptive Diagnostics technology at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Dec. 1–6, 2013 (Booth #7330, North Hall).

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.